articleTop 10% cited

Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke

Stroke · 2003 · Vol. 34(8) · pp. e109–37

Randall T. Higashida✉(Society of Interventional Radiology)Anthony J. Furlan(Society of Interventional Radiology)

Abstract

In summary, this article serves to provide a more uniform set of criteria for clinical trials and reporting outcomes used in designing stroke trials involving intra-arterial thrombolytic agents, either alone or in combination with other therapies. It is anticipated that by having a more uniform set of reporting standards, more meaningful analysis of the data and the literature will be able to be achieved.

Acute Ischemic Stroke Management Stroke Rehabilitation and Recovery Cerebrovascular and Carotid Artery DiseasesMedicineThrombolysisStroke (engine)Clinical trialTissue plasminogen activatorIntensive care medicineRandomized controlled trialFibrinolytic agentEmergency medicineInternal medicine

MeSH terms

Acute DiseaseBrain IschemiaClinical Trials as TopicFibrinolytic AgentsHumansInjections, Intra-ArterialMagnetic Resonance ImagingTerminology as TopicResearch DesignTechnology Assessment, BiomedicalTime FactorsTomography, X-Ray ComputedUnited StatesMulticenter Studies as TopicThrombolytic Therapy

Citations

1,508

FWCI

10.64

field-weighted impact

References

120

Percentile

99%

vs. same field & year

Citations per year

Cited by